224 related articles for article (PubMed ID: 37614665)
1. Fibroblast activation protein-α expression in fibroblasts is common in the tumor microenvironment of colorectal cancer and may serve as a therapeutic target.
Greimelmaier K; Klopp N; Mairinger E; Wessolly M; Borchert S; Steinborn J; Schmid KW; Wohlschlaeger J; Mairinger FD
Pathol Oncol Res; 2023; 29():1611163. PubMed ID: 37614665
[No Abstract] [Full Text] [Related]
2. The Prognostic and therapeutic value and clinical implications of fibroblast activation protein-α as a novel biomarker in colorectal cancer.
Kalaei Z; Manafi-Farid R; Rashidi B; Kiani FK; Zarei A; Fathi M; Jadidi-Niaragh F
Cell Commun Signal; 2023 Jun; 21(1):139. PubMed ID: 37316886
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Cancer-Associated Fibroblasts on the Biology and Progression of Colorectal Carcinomas.
Henrich LM; Greimelmaier K; Wessolly M; Klopp NA; Mairinger E; Krause Y; Berger S; Wohlschlaeger J; Schildhaus HU; Baba HA; Mairinger FD; Borchert S
Genes (Basel); 2024 Feb; 15(2):. PubMed ID: 38397199
[TBL] [Abstract][Full Text] [Related]
4. Altered expression of fibroblast activation protein-α (FAP) in colorectal adenoma-carcinoma sequence and in lymph node and liver metastases.
Solano-Iturri JD; Beitia M; Errarte P; Calvete-Candenas J; Etxezarraga MC; Loizate A; Echevarria E; Badiola I; Larrinaga G
Aging (Albany NY); 2020 May; 12(11):10337-10358. PubMed ID: 32428869
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of cancer-associated fibroblast markers at the invasive front and its association with tumor-stroma ratio in colorectal cancer.
Sandberg TP; Stuart MPME; Oosting J; Tollenaar RAEM; Sier CFM; Mesker WE
BMC Cancer; 2019 Mar; 19(1):284. PubMed ID: 30922247
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast activation protein-positive fibroblasts promote tumor progression through secretion of CCL2 and interleukin-6 in esophageal squamous cell carcinoma.
Higashino N; Koma YI; Hosono M; Takase N; Okamoto M; Kodaira H; Nishio M; Shigeoka M; Kakeji Y; Yokozaki H
Lab Invest; 2019 Jun; 99(6):777-792. PubMed ID: 30683902
[TBL] [Abstract][Full Text] [Related]
7. [Expression of CD10 in cancer-associated fibroblasts and its effect on initiation and progression of colorectal carcinoma].
Zhu Y; Zheng JJ; Yang F; Nie QQ; Zhu ZL; Deng H
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):859-865. PubMed ID: 28056302
[No Abstract] [Full Text] [Related]
8. Microenvironmental markers are correlated with lymph node metastasis in invasive submucosal colorectal cancer.
Sugai T; Yamada N; Osakabe M; Hashimoto M; Uesugi N; Eizuka M; Tanaka Y; Sugimoto R; Yanagawa N; Matsumoto T
Histopathology; 2021 Oct; 79(4):584-598. PubMed ID: 33884652
[TBL] [Abstract][Full Text] [Related]
9. FAP positive fibroblasts induce immune checkpoint blockade resistance in colorectal cancer via promoting immunosuppression.
Chen L; Qiu X; Wang X; He J
Biochem Biophys Res Commun; 2017 May; 487(1):8-14. PubMed ID: 28302482
[TBL] [Abstract][Full Text] [Related]
10. [Multiplex fluorescent imaging of cancer-associated fibroblasts in colorectal cancer].
Oleynikova NA; Kharlova OA; Danilova NV; Malkov PG
Arkh Patol; 2022; 84(5):11-19. PubMed ID: 36178217
[TBL] [Abstract][Full Text] [Related]
11. [FIBROBLAST ACTIVATION PROTEIN (FAP) AS A POSSIBLE TARGET OF THE ANTITUMOR STRATEGY.].
Pleshkan VV; Alekseenko IV; Tyulkina DV; Kyzmich AI; Zinovyeva MV; Sverdlov ED
Mol Gen Mikrobiol Virusol; 2016; 34(3):90-97. PubMed ID: 30383930
[TBL] [Abstract][Full Text] [Related]
12. Broadening Drug Design and Targets to Tumor Microenvironment? Cancer-Associated Fibroblast Marker Expression in Cancers and Relevance for Survival Outcomes.
Dzobo K; Dandara C
OMICS; 2020 Jun; 24(6):340-351. PubMed ID: 32496971
[TBL] [Abstract][Full Text] [Related]
13. The Origin and Contribution of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis.
Kobayashi H; Gieniec KA; Lannagan TRM; Wang T; Asai N; Mizutani Y; Iida T; Ando R; Thomas EM; Sakai A; Suzuki N; Ichinose M; Wright JA; Vrbanac L; Ng JQ; Goyne J; Radford G; Lawrence MJ; Sammour T; Hayakawa Y; Klebe S; Shin AE; Asfaha S; Bettington ML; Rieder F; Arpaia N; Danino T; Butler LM; Burt AD; Leedham SJ; Rustgi AK; Mukherjee S; Takahashi M; Wang TC; Enomoto A; Woods SL; Worthley DL
Gastroenterology; 2022 Mar; 162(3):890-906. PubMed ID: 34883119
[TBL] [Abstract][Full Text] [Related]
14. Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model.
Meng M; Wang W; Yan J; Tan J; Liao L; Shi J; Wei C; Xie Y; Jin X; Yang L; Jin Q; Zhu H; Tan W; Yang F; Hou Z
Tumour Biol; 2016 Aug; 37(8):10317-27. PubMed ID: 26842926
[TBL] [Abstract][Full Text] [Related]
15. TGF-β1 dominates stromal fibroblast-mediated EMT via the FAP/VCAN axis in bladder cancer cells.
Ping Q; Wang C; Cheng X; Zhong Y; Yan R; Yang M; Shi Y; Li X; Li X; Huang W; Wang L; Bi X; Hu L; Yang Y; Wang Y; Gong R; Tan J; Li R; Li H; Li J; Wang W; Li R
J Transl Med; 2023 Jul; 21(1):475. PubMed ID: 37461061
[TBL] [Abstract][Full Text] [Related]
16. The application of the fibroblast activation protein α-targeted immunotherapy strategy.
Jiang GM; Xu W; Du J; Zhang KS; Zhang QG; Wang XW; Liu ZG; Liu SQ; Xie WY; Liu HF; Liu JS; Wu BP
Oncotarget; 2016 May; 7(22):33472-82. PubMed ID: 26985769
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor receptor 2/AKT and ERK signaling pathways contribute to the switch from fibroblasts to CAFs by progranulin in microenvironment of colorectal cancer.
Wang L; Yang D; Tian J; Gao A; Shen Y; Ren X; Li X; Jiang G; Dong T
Oncotarget; 2017 Apr; 8(16):26323-26333. PubMed ID: 28412748
[TBL] [Abstract][Full Text] [Related]
18. PROX1 interaction with α-SMA-rich cancer-associated fibroblasts facilitates colorectal cancer progression and correlates with poor clinical outcomes and therapeutic resistance.
Lai SW; Cheng YC; Kiu KT; Yen MH; Chen YW; Yadav VK; Yeh CT; Kuo KT; Chang TC
Aging (Albany NY); 2024 Jan; 16(2):1620-1639. PubMed ID: 38244581
[TBL] [Abstract][Full Text] [Related]
19. Exosomes Derived from Human Primary and Metastatic Colorectal Cancer Cells Contribute to Functional Heterogeneity of Activated Fibroblasts by Reprogramming Their Proteome.
Rai A; Greening DW; Chen M; Xu R; Ji H; Simpson RJ
Proteomics; 2019 Apr; 19(8):e1800148. PubMed ID: 30582284
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast heterogeneity in solid tumors: From single cell analysis to whole-body imaging.
Peltier A; Seban RD; Buvat I; Bidard FC; Mechta-Grigoriou F
Semin Cancer Biol; 2022 Nov; 86(Pt 3):262-272. PubMed ID: 35489628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
